Expert Cancer Panel: Relapsed/refractory follicular lymphoma

4 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
Recorded on 7/24/2021

69 year old female with relapsed/refractory follicular lymphoma

Summary:
- Treatment options for patients with relapsed/refractory follicular lymphoma after two prior lines of chemoimmunotherapy include the EZH2 inhibitor tazemetostat, PI3K inhibitors, lenalidomide and rituximab, bispecific antibodies, and anti-CD19 CAR T-cell therapies, but the ultimate decision should be made mutually with the patient and is dependent on patient goals and comorbidities.


At PrecisCa, we are dedicated to providing expert second opinions for cancer patients to ensure they receive the best possible care. Our videos cover a wide range of topics related to oncology, including in-depth discussions on different types of cancer, treatment options, patient stories, and the latest advancements in cancer research. Whether you're a patient, caregiver, or simply seeking to expand your knowledge, our goal is to support you on your healthcare journey.

Visit our website: https://www.PrecisCa.com for more detailed information and personalized second opinions.

Stay connected with us:
Facebook: / precisca.oncology
Twitter: https://twitter.com/precisca_?lang=en
-Instagram: / precisca_oncology
-LinkedIn: / precisca

Don't forget to subscribe to our channel for regular updates and new videos. Hit the bell icon to receive notifications every time we upload. #Oncology #CancerCare #CancerSupport #CancerResearch #Health #Healthcare #CancerTreatment #CancerAwareness #PatientCare #MedicalAdvice #PrecisCa
Category
Oncology
Be the first to comment

Up Next